Control Material for Quality Control of Quantitative Determination of Antibodies to Hepatitis B Surface Antigen in Clinical Samples by Chemiluminescent Immunoassay on CL Series Analyzers
Control materials designed for quality control of the quantitative determination of antibodies to the Hepatitis B surface antigen (Anti-HBs) in clinical samples using chemiluminescent immunoassay (CLIA) on CL series analyzers.
Available Versions:
1. Negative Control Material
Purpose: For quality control of quantitative Anti-HBs antibody determination in clinical samples using CLIA.
Package: 3 x 2.0 mL/vial
Composition:
- Anti-HBs Negative Control, 2.0 mL – 3 vials
Included: Control material lot value chart, instruction manual
2. Negative Control Material
Purpose: For quality control of quantitative Anti-HBs antibody determination in clinical samples using CLIA.
Package: 6 x 2.0 mL/vial
Composition:
- Anti-HBs Negative Control, 2.0 mL – 6 vials
Included: Control material lot value chart, instruction manual
3. Positive Control Material
Purpose: For quality control of quantitative Anti-HBs antibody determination in clinical samples using CLIA.
Package: 3 x 2.0 mL/vial
Composition:
- Anti-HBs Positive Control, 2.0 mL – 3 vials
Included: Control material lot value chart, instruction manual
4. Positive Control Material
Purpose: For quality control of quantitative Anti-HBs antibody determination in clinical samples using CLIA.
Package: 6 x 2.0 mL/vial
Composition:
- Anti-HBs Positive Control, 2.0 mL – 6 vials
Included: Control material lot value chart, instruction manual
If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Control Material for Quality Control of Quantitative Determination of Antibodies to Hepatitis B Surface Antigen in Clinical Samples by Chemiluminescent Immunoassay on CL Series Analyzers, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.
The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.
